GlassScriptPhysician profile
Melissa A Tarnowski
NPI 1639117195
$9,064.47
in general payments reported to CMS, 2019-2025
65 companies · $3,009 in 2025
The $3,009 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $590 · 2022: $1,174 · 2023: $1,897 · 2024: $2,395 · 2025: $3,009.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,113 · Education: $187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,113.01 |
| Education | $187.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,381.70 | 2021-2025 | |
| Ucb, INC. | $1,295.26 | 2021-2025 | Rystiggo, Nayzilam, Briviact |
| Sk Life Science, INC. | $471.18 | 2021-2025 | |
| Tg Therapeutics, INC. | $444.84 | 2023-2025 | |
| Pfizer INC. | $419.72 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $369.82 | 2023-2025 | Rexulti |
| Lilly USA, LLC | $354.27 | 2023-2025 | Kisunla, Mounjaro, Zepbound |
| Teva Pharmaceuticals USA, INC. | $289.32 | 2023-2025 | Austedo Xr, Austedo, Austedo Xr |
| Lundbeck LLC | $258.23 | 2023-2025 | Rexulti, Vyepti |
| Biogen, INC. | $246.09 | 2022-2024 | Vumerity, Tysabri |
| Celgene Corporation | $239.84 | 2021-2025 | Zeposia |
| Eisai INC. | $220.81 | 2024-2025 | |
| Mdd US Operations, LLC | $216.74 | 2021-2025 | Gocovri, Gocovri, Apokyn |
| Novartis Pharmaceuticals Corporation | $213.18 | 2021-2025 | |
| Neurocrine Biosciences, INC. | $211.44 | 2023-2025 | Ingrezza, Ongentys |
Show all 65 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $189.46 | 2023-2025 | Valtoco |
| Alexion Pharmaceuticals, INC. | $154.70 | 2022-2025 | Ultomiris |
| Impel Pharmaceuticals INC. | $152.17 | 2022-2023 | Trudhesa |
| Janssen Biotech, INC. | $99.99 | 2025 | |
| Genentech USA, INC. | $90.42 | 2024-2025 | Ocrevus Zunovo, Ocrevus |
| Supernus Pharmaceuticals, INC. | $88.92 | 2021-2025 | Qelbree |
| Argenx US, INC. | $83.80 | 2023-2024 | Vyvgart, Vyvgart Hytrulo |
| Vanda Pharmaceuticals INC. | $83.20 | 2021-2025 | Ponvory |
| Kyowa Kirin, INC. | $80.88 | 2021-2022 | |
| Livanova USA, INC. | $78.76 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Takeda Pharmaceuticals U.S.A., INC. | $78.23 | 2023-2025 | Hyqvia, Trintellix |
| Biohaven Pharmaceutical Holding Company LTD. | $75.31 | 2022 | |
| Edwards Lifesciences Corporation | $74.33 | 2024-2025 | Sapien 3 Ultra Resilia |
| Allergan, INC. | $72.27 | 2021-2022 | |
| Csl Behring | $69.76 | 2023 | Hizentra |
| Novo Nordisk INC | $66.15 | 2023-2025 | Ozempic, Rybelsus |
| E.R. Squibb & Sons, L.L.C. | $65.51 | 2021-2024 | Camzyos, Eliquis |
| Emd Serono, INC. | $51.66 | 2025 | Mavenclad |
| Amgen INC. | $50.56 | 2024 | Uplizna |
| Averitas Pharma INC. | $44.87 | 2024 | Qutenza |
| Ge Healthcare | $41.25 | 2021-2024 | |
| Tanabe Pharma America, INC. | $41.20 | 2024 | |
| Horizon Therapeutics Plc | $37.77 | 2023 | Uplizna |
| Janssen Pharmaceuticals, INC | $35.83 | 2021 | |
| Acorda Therapeutics, INC | $32.35 | 2023 | Ampyra, Inbrija |
| Scilex Pharmaceuticals INC. | $31.09 | 2024-2025 | |
| Jazz Pharmaceuticals INC. | $28.80 | 2025 | |
| Amneal Pharmaceuticals LLC | $27.11 | 2022-2023 | Rytary |
| Catalyst Pharmaceuticals, INC. | $22.73 | 2024 | |
| Abbott Laboratories | $22.68 | 2025 | Freestyle Libre 3 |
| Xeris Pharmaceuticals, INC. | $22.14 | 2022 | |
| Merz Pharmaceuticals, LLC | $21.98 | 2025 | Inbrija, Xeomin |
| Glaxosmithkline, LLC. | $21.67 | 2023 | Shingrix, Trelegy Ellipta |
| Sumitomo Pharma America, INC. | $21.59 | 2023 | Aptiom |
| Phathom Pharmaceuticals, INC. | $21.00 | 2024 | Voquezna |
| Merck Sharp & Dohme LLC | $20.67 | 2024 | Gardasil, Gardasil 9 |
| Cycle Pharmaceuticals INC | $20.44 | 2024 | Tascenso Odt |
| Astrazeneca Pharmaceuticals LP | $20.28 | 2025 | Wainua |
| Sunovion Pharmaceuticals INC. | $20.00 | 2021 | |
| Alnylam Pharmaceuticals INC. | $19.68 | 2024 | Onpattro |
| Impel Pharmaceuticals LLC | $18.34 | 2025 | Trudhesa |
| Upsher-Smith Laboratories LLC | $18.11 | 2021 | |
| Verona Pharma, INC. | $17.50 | 2025 | Ohtuvayre |
| Boston Scientific Corporation | $17.12 | 2025 | Watchman Flx |
| Axsome Therapeutics, INC. | $15.39 | 2025 | Symbravo |
| Genzyme Corporation | $14.82 | 2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.27 | 2025 | Caplyta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.83 | 2024 | Jardiance |
| Kowa Pharmaceuticals America, INC. | $13.51 | 2023 | Seglentis |
| Metacel Pharmaceuticals LLC | $7.93 | 2023 | Ozobax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Tarnowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.